A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.
In search of how children develop severe allergies and autoimmune disorders, Nitya Jain, PhD, at MassGeneral Hospital for Children, is studying how the immune system’s T cells communicate with bacteria in the gut.
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
A new initiative from the Department of Medicine at Mass General, the Pathways Service provides a way for medical residents to discuss unusual patient cases and initiate research projects based on the questions the cases raise.
Through the MGH Asylum Clinic, physician-volunteers from Mass General support asylum seekers by providing medical evidence of past trauma.
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Mass General researcher Caroline Mitchell, MD, PhD, is studying how microbial changes in the female reproductive tract can lead to health complications across the lifecycle of women.
A recent study helps to confirm the theory that Tourette syndrome results from a complex series of genetic changes rather than a single mutated gene.
Mass General researchers hope to create new treatments for shigellosis, a potentially fatal digestive disorder, by factoring in genetic changes that occur in Shigella bacteria in the human digestive system.